{"product_id":"nano-check-influenza-a-b-test","title":"Nano-Check Influenza A+B Test","description":"\u003cp\u003eThe \u003cstrong\u003eNano-Check™ Influenza A+B Test\u003c\/strong\u003e is a rapid lateral flow immunochromatographic assay designed for the \u003cstrong\u003equalitative detection and differentiation of Influenza A and Influenza B nucleoprotein antigens\u003c\/strong\u003e from anterior nasal swab specimens in patients showing signs and symptoms of respiratory infection. It is intended to aid healthcare professionals in the differential diagnosis of Influenza A and Influenza B infections. \u003cspan class=\"contents\"\u003e\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003eThe test provides visually readable results in approximately \u003cstrong\u003e15 minutes\u003c\/strong\u003e and is designed for use with the anterior nasal swabs supplied in the kit. It is \u003cstrong\u003eCLIA waived for anterior nasal swab testing\u003c\/strong\u003e, intended for prescription and in vitro diagnostic use, and requires no specialized laboratory instrumentation. Each kit contains \u003cstrong\u003e25 tests\u003c\/strong\u003e, along with extraction buffer, sample collection swabs, and positive and negative control swabs. \u003cspan class=\"contents\"\u003e\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003eClinical testing reported a \u003cstrong\u003ePositive Percent Agreement of 86.9% for Influenza A and 86.8% for Influenza B\u003c\/strong\u003e, with Negative Percent Agreement of \u003cstrong\u003e99.6% and 99.7%\u003c\/strong\u003e, respectively, compared with an FDA-cleared RT-PCR method.\u003c\/p\u003e","brand":"Kay Scientific","offers":[{"title":"Default Title","offer_id":45810277974063,"sku":null,"price":150.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0583\/6151\/1983\/files\/nanofluab1.png?v=1786477693","url":"https:\/\/www.kayscientific.com\/products\/nano-check-influenza-a-b-test","provider":"Kay Scientific","version":"1.0","type":"link"}